AAAAAA
Results: 1-25/32
Authors:
PLOTKIN S
Citation: S. Plotkin, CLINICAL COMPARISON OF PREINJECTION ANESTHETICS, Journal of the American Podiatric Medical Association, 88(2), 1998, pp. 73-79
Authors:
PLOTKIN S
Citation: S. Plotkin, THE ANTIINFLAMMATORY ACTION OF LOCALLY INJECTED KETOROLAC, Journal of the American Podiatric Medical Association, 88(2), 1998, pp. 105-106
Authors:
TARTAGLIA J
EXCLER JL
ELHABIB R
LIMBACH K
MEIGNIER B
PLOTKIN S
KLEIN M
Citation: J. Tartaglia et al., CANARYPOX VIRUS-BASED VACCINES - PRIME-BOOST STRATEGIES TO INDUCE CELL-MEDIATED AND HUMORAL IMMUNITY AGAINST HIV, AIDS research and human retroviruses, 14, 1998, pp. 291-298
Authors:
KAMATH L
PALMON O
PLOTKIN S
Citation: L. Kamath et al., ROUTING AND ADMISSION CONTROL IN GENERAL TOPOLOGY NETWORKS WITH POISSON ARRIVALS, Journal of algorithms, 27(2), 1998, pp. 236-258
Authors:
PLOTKIN S
HAIM A
Citation: S. Plotkin et A. Haim, KINETICS AND MECHANISM OF THE OXIDATION OF AMMINERUTHENIUM(II) COMPLEXES BY BROMINE, Inorganica Chimica Acta, 270(1-2), 1998, pp. 189-196
Authors:
ASPNES J
AZAR Y
FIAT A
PLOTKIN S
WAARTS O
Citation: J. Aspnes et al., ONLINE ROUTING OF VIRTUAL CIRCUITS WITH APPLICATIONS TO LOAD BALANCING AND MACHINE SCHEDULING, Journal of the ACM, 44(3), 1997, pp. 486-504
Authors:
VIDOR E
MESCHIEVITZ C
PLOTKIN S
Citation: E. Vidor et al., 15 YEARS OF EXPERIENCE WITH VERO-PRODUCED ENHANCED POTENCY INACTIVATED POLIOVIRUS VACCINE, The Pediatric infectious disease journal, 16(3), 1997, pp. 312-322
Authors:
EXCLER JL
PLOTKIN S
Citation: Jl. Excler et S. Plotkin, THE PRIME-BOOST CONCEPT APPLIED TO HIV PREVENTIVE VACCINES, AIDS, 11, 1997, pp. 127-137
Authors:
AZAR Y
KALYANASUNDARAM B
PLOTKIN S
PRUHS KR
WAARTS O
Citation: Y. Azar et al., ONLINE LOAD BALANCING OF TEMPORARY TASKS, Journal of algorithms, 22(1), 1997, pp. 93-110
Authors:
MA Y
PLOTKIN S
Citation: Y. Ma et S. Plotkin, AN IMPROVED LOWER-BOUND FOR LOAD BALANCING OF TASKS WITH UNKNOWN DURATION, Information processing letters, 62(6), 1997, pp. 301-303
Authors:
PLOTKIN S
Citation: S. Plotkin, CASE PRESENTATION OF CALCANEONAVICULAR COALITION IN MONOZYGOTIC TWINS, Journal of the American Podiatric Medical Association, 86(9), 1996, pp. 433-438
Authors:
AFEK Y
AWERBUCH B
PLOTKIN S
SAKS M
Citation: Y. Afek et al., LOCAL-MANAGEMENT OF A GLOBAL RESOURCE IN A COMMUNICATION-NETWORK, Journal of the ACM, 43(1), 1996, pp. 1-19
Authors:
VIDOR E
FRITZELL B
PLOTKIN S
Citation: E. Vidor et al., CLINICAL DEVELOPMENT OF A NEW INACTIVATED HEPATITIS-A VACCINE, Infection, 24(6), 1996, pp. 447-458
Authors:
KAPLAN C
MORELKOPP MC
KIENY MP
KOLBE H
SALMON D
SICARD D
PIALOUX G
MEIGNIER B
EXCLER JL
PLOTKIN S
Citation: C. Kaplan et al., ANTIPLATELET ANTIBODIES DURING THE COURSE OF HIV-PREVENTIVE VACCINE TRIAL, AIDS, 10(4), 1996, pp. 447-449
Authors:
MURDIN AD
BARRETO L
PLOTKIN S
Citation: Ad. Murdin et al., INACTIVATED POLIOVIRUS VACCINE - PAST AND PRESENT EXPERIENCE, Vaccine, 14(8), 1996, pp. 735-746
Authors:
FRIES LF
TARTAGLIA J
TAYLOR J
KAUFFMAN EK
MEIGNIER B
PAOLETTI E
PLOTKIN S
Citation: Lf. Fries et al., HUMAN SAFETY AND IMMUNOGENICITY OF A CANARYPOX-RABIES GLYCOPROTEIN RECOMBINANT VACCINE - AN ALTERNATIVE POXVIRUS VECTOR SYSTEM, Vaccine, 14(5), 1996, pp. 428-434
Authors:
PIALOUX G
EXCLER JL
RIVIERE Y
GONZALEZCANALI G
FEUILLIE V
COULAUD P
GLUCKMAN JC
MATTHEWS TJ
MEIGNIER B
KIENY MP
GONNET P
DIAZ I
MERIC C
PAOLETTI E
TARTAGLIA J
SALOMON H
PLOTKIN S
Citation: G. Pialoux et al., A PRIME-BOOST APPROACH TO HIV PREVENTIVE VACCINE USING A RECOMBINANT CANARYPOX VIRUS EXPRESSING GLYCOPROTEIN-160 (MN) FOLLOWED BY A RECOMBINANT GLYCOPROTEIN-160 (MN LAI)/, AIDS research and human retroviruses, 11(3), 1995, pp. 373-381
Authors:
SALMONCERON D
EXCLER JL
SICARD D
BLANCHE P
FINKIELSTZJEN L
GLUCKMAN JC
AUTRAN B
MATTHEWS TJ
MEIGNIER B
KIENY MP
VALENTIN C
GONNET P
DIAZ I
SALOMON H
PIALOUX G
GONZALEZCANALI G
PLOTKIN S
Citation: D. Salmonceron et al., SAFETY AND IMMUNOGENICITY OF A RECOMBINANT HIV TYPE-1 GLYCOPROTEIN-160 BOOSTED BY A V3 SYNTHETIC PEPTIDE IN HIV-NEGATIVE VOLUNTEERS, AIDS research and human retroviruses, 11(12), 1995, pp. 1479-1486
Authors:
EXCLER JL
SALMON D
SICARD D
AUTRAN B
GLUCKMAN JC
MATTHEWS TJ
MOOG C
MEIGNIER B
PAOLETTI E
TARTAGLIA J
KLEIN G
CHONG P
PLOTKIN S
Citation: Jl. Excler et al., SAFETY AND IMMUNOGENICITY OF A LIVE RECOMBINANT CANARYPOX VIRUS-VACCINE EXPRESSING GP120 GAG/PROTEASE BOOSTED BY A P24E-V3/, AIDS research and human retroviruses, 11, 1995, pp. 138-138
Authors:
PLOTKIN S
Citation: S. Plotkin, COMPETITIVE ROUTING OF VIRTUAL CIRCUITS IN ATM NETWORKS, IEEE journal on selected areas in communications, 13(6), 1995, pp. 1128-1136
Authors:
RIVIERE Y
JANVIER G
FLEURY B
EXCLER JL
PLOTKIN S
PIALOUX G
TARTAGLIA J
Citation: Y. Riviere et al., INDUCTION OF CYTOTOXIC-T-LYMPHOCYTE ACTIVITY BY HIV-GP160 RECOMBINANTCANARYPOXVIRUS - CTL MEMORY WITHOUT ANTIGEN, Journal of cellular biochemistry, 1995, pp. 304-304
Authors:
LEIGHTON T
MAKEDON F
PLOTKIN S
STEIN C
TARDOS E
TRAGOUDAS S
Citation: T. Leighton et al., FAST APPROXIMATION ALGORITHMS FOR MULTICOMMODITY FLOW PROBLEMS, Journal of computer and system sciences, 50(2), 1995, pp. 228-243
Authors:
VIDOR E
CAUDRELIER P
PLOTKIN S
Citation: E. Vidor et al., THE PLACE OF DTP EIPV VACCINE IN ROUTINE PEDIATRIC VACCINATION, Reviews in medical virology, 4(4), 1994, pp. 261-277
Authors:
SALMON D
EXCLER JL
PLOTKIN S
PIALOUX G
RIVIERE Y
AUTRAN B
GLUCKMAN JC
MATTHEWS T
Citation: D. Salmon et al., A PRIME-BOOST APPROACH TO HIV PREVENTIVE VACCINES USING A MN-GP160 RECOMBINANT CANARYPOX VIRUS AND ENVELOPE SUBUNITS (RGP160, V3 PEPTIDE), AIDS research and human retroviruses, 10, 1994, pp. 190000156-190000156
Authors:
MEIGNIER B
PIALOUX G
SALMON D
SICARD D
PLOTKIN S
Citation: B. Meignier et al., HIV VACCINES IN CLINICAL-TRIALS - A RECOMBINANT CANARYPOX VIRUS, A CHIMERIC RGP160 AND A SYNTHETIC PEPTIDE IN PRIME BOOST COMBINATIONS/, AIDS research and human retroviruses, 10, 1994, pp. 190000049-190000049